Amlodipine/Valsartan [Design Issues]

posted by Kumarnaidu2 – India, 2023-12-07 03:42 (483 d 00:52 ago) – Posting: # 23786
Views: 2,827

Hello dshah

❝ I believe that for Amlodipine the ISCV would be LT 30%, so by default the ABE calculation becomes applicable. So what advantages would be there to have such statistical plan?

❝ Further- analysis of Amlodipine would be required to link any AE for last period. And if it is analyzed, what can be the justification for not using in PK stat?


The reported ISCV for Amlodipine is around 9 to 12%.

Complete thread:

UA Flag
Activity
 Admin contact
23,412 posts in 4,923 threads, 1,667 registered users;
106 visitors (0 registered, 106 guests [including 5 identified bots]).
Forum time: 05:34 CEST (Europe/Vienna)

Genius is that which forces
the inertia of humanity to learn.    Henri Bergson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5